0001264124-12-000037.txt : 20120210 0001264124-12-000037.hdr.sgml : 20120210 20120210205509 ACCESSION NUMBER: 0001264124-12-000037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120208 FILED AS OF DATE: 20120210 DATE AS OF CHANGE: 20120210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KOLTERMAN ORVILLE G CENTRAL INDEX KEY: 0001236394 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19700 FILM NUMBER: 12594972 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS INC STREET 2: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMYLIN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000881464 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330266089 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195522200 MAIL ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0304 4 2012-02-08 0 0000881464 AMYLIN PHARMACEUTICALS INC AMLN 0001236394 KOLTERMAN ORVILLE G 9360 TOWNE CENTRE DR SAN DIEGO CA 92121 0 1 0 0 SVP, Chief Medical Officer Common Stock 2012-02-08 4 A 0 15000 0 A 171456.9 D Common Stock 2012-02-08 4 S 0 5637 16.6154 D 165819.9 D Common Stock 12767.3 I Indirect-401k Common Stock 6445.1 I by ESOP Represents shares acquired upon vesting of performance-based restricted stock units. Sale of common shares to satisfy reporting person's income tax withholding obligations due upon vesting of performance-based restricted stock units. These shares fully vested four years from the date of the reporting person's participation in the ESOP in four equal annual installments and are generally distributed upon termination of employment. By: /s/ James R. Oehler, Attorney-in-Fact For: Orville G. Kolterman 2012-02-10